Combined contributions of cytochrome P450s (CYPs) and non-enzymatic metabolism in the in vitro biotransformation of anaprazole, a novel proton pump inhibitor
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00210-023-02415-7.pdf
Reference34 articles.
1. Bertilsson L (1995) Geographical/interracial differences in polymorphic drug oxidation Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19. Clin Pharmacokinet 29(3):192–209
2. Blume H et al (2006) Pharmacokinetic drug interaction profiles of proton pump inhibitors. Drug Saf 29(9):769–784
3. Chaudhry AS, Kochhar R, Kohli KK (2008) Genetic polymorphism of CYP2C19 & therapeutic response to proton pump inhibitors. Indian J Med Res 127(6):521–530
4. Chawla PK et al (2015) Correlation of CYP2C19 genotype with plasma voriconazole levels: a preliminary retrospective study in Indians. Int J Clin Pharm 37(5):925–930
5. Cheng DX et al (2016) Determination of anaprazole in human plasma by LC-MS/MS in pharmacokinetic study. Yao Xue Xue Bao 51(12):1885–1890
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3